Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Vaginal Atrophy clinical trials
Every US clinical trial registered for Vaginal Atrophy — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
10 US clinical trials · 4 currently recruiting
The research picture
Vaginal Atrophy has 10 registered US clinical trials, 4 of them open to new participants right now — about 40% of the total.
- 4
- recruiting participants now
- 40%
- of trials open to enrollment
- 6
- in Phase 3–4 (later-stage)
- 2
- top sponsor: Stratpharma
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
Stratpharma
NCT05953090
Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo
Maimonides Medical Center
NCT04807894
Postpartum Vaginal Estrogen for Breastfeeding Patients
University Hospitals Cleveland Medical Center
NCT05457972
ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy
Stratpharma
NCT07346287
PRP Injections for Genitourinary Syndrome of Menopause
Medstar Health Research Institute
NCT06028009
Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause
Wyeth is now a wholly owned subsidiary of Pfizer
NCT00238732
Topical DHEA Against Vaginal Atrophy
EndoCeutics
NCT01846442
Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause
Sciton
NCT03178825
Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy
University of Alabama at Birmingham
NCT03996603
Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
Alma Lasers
NCT02747641
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
| Phase 4 | 4 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Vaginal Atrophy Trial Landscape
ClinicalTrials.gov lists 10 US studies indexed under Vaginal Atrophy, and 4 of those are currently open to recruitment — roughly 40% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Vaginal Atrophy shows 6 late-stage studies (Phase 3 and Phase 4 combined) alongside 0 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Vaginal Atrophy is led by Stratpharma with 2 indexed trials, alongside 8 other organizations in the top contributor list. The list on this page surfaces up to 10 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Vaginal Atrophy?
PlainTrial tracks 10 US clinical trials for Vaginal Atrophy, of which 4 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Vaginal Atrophy?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.